Topic List : Cancer
E-cigarette flavorings harm blood vessel cells
E-cigarette flavorings damage human blood vessel cells grown in the lab even in the absence of nicotine, Stanford researchers and their colleagues found. Cinnamon and menthol flavors were particularly harmful.
Surgeons turn to basic science in cancer fight
In 2012, a pair of neurosurgery residents traded their scrubs for lab coats in an effort to understand, at the most basic level, what causes medulloblastoma, the most common pediatric brain cancer.
Targeting cancer, sparing healthy cells
Stanford researchers have developed synthetic proteins that can rewire cancer cells in a lab dish by co-opting critical disease-associated pathways.
Taubes give $6 million for cancer research
The gift will advance research on cancer therapies at the School of Medicine and Lucile Packard Children’s Hospital Stanford.
Ovarian cancer mutations undertested
A large study of women with breast and ovarian cancer has revealed significant gaps between national guidelines for genetic testing and actual testing practices, according to researchers from Stanford and five other institutions.
Colon cancer testing at 45 would avert deaths
A Stanford-led study found that increasing the participation of older adults in colorectal cancer screening would help prevent more deaths than expanding testing to people in their 40s.
Immune cell-based cancer diagnostics
Stanford scientists were able to engineer immune cells known as macrophages to detect and flag cancer in mice. The researchers hope the technique can be used for early cancer diagnostics in humans.
Discovery could limit toxic effect of chemo
Stanford researchers have found a way to predict who will suffer heart problems from a common breast-cancer drug, as well as identified an FDA-approved medication that could mitigate those side effects.
Molecular data categorizes breast cancers
Some breast cancers return decades later. Now, a researcher at Stanford, joined by collaborators at several other institutions, has subcategorized tumors to predict recurrence, guide treatment decisions and improve drug development.
Urine test for bladder cancer
The researchers found that by testing for fragments of cancer DNA in urine, they could find the cancer in early stages of development, when it’s easier to treat.